Quest Diagnostics logo

Quest Diagnostics (DGX) Q1 2026 Earnings

DGX·Reported April 21, 2026·Before market open

Quest Diagnostics reported Q1 2026 revenue of $2.9B, beat analyst consensus of $2.8B by $66.5M. Diluted EPS came in at $2.50, beat the $2.37 consensus by $0.13. Quest Diagnostics reports across 2 business segments, led by Diagnostic Information Services and Diagnostic Solutions.

Revenue
$2.9Bbeat by $66.5M
Consensus: $2.8B
Diluted EPS
$2.50beat by $0.13
Consensus: $2.37
SEC

SEC Filings

Earnings release8-K · 0001022079-26-000040
Quarterly report10-Q · 0001022079-26-000043

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Quest Diagnostics's Q1 2026 earnings report.

Quest Diagnostics (DGX) reported Q1 2026 earnings on April 21, 2026 before market open.

Quest Diagnostics reported revenue of $2.9B and diluted EPS of $2.50 for Q1 2026.

Revenue beat the consensus estimate of $2.8B by $66.5M. EPS beat the consensus estimate of $2.37 by $0.13.

You can read the 8-K earnings release (0001022079-26-000040) and the 10-Q periodic report (0001022079-26-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.